Business Standard

Study in hamsters shows convalescent plasma limits Covid-19 spread in lungs

According to the research, the lung injuries seen in the hamsters include lesions in X-ray scans called "ground glass opacities" which are also reported in human Covid-19 patients.

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

The study noted that lung damage persisted for 14 days in a majority of the animals, and for at least 20 days in most of those infected with a high dose.

Press Trust of India
Prior infection with the novel coronavirus provides protection against reinfection, according to a new study in hamsters which showed that treatment with convalescent serum limits virus replication in their lungs.

Researchers, including Yoshihiro Kawaoka from the University of Wisconsin-Madison in the US, demonstrated that both low and high doses of the novel corovirus, SARS-COV-2 replicate well in the airways of juvenile as well as adult hamsters.

"SARS-CoV-2-infected hamsters mounted neutralising antibody responses and were protected against rechallenge with SARS-CoV-2," the study, published in the journal PNAS, noted.

They said the virus can also infect both the upper and lower respiratory

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in